Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Treasury Shares (2019 - 2022)

Cue Biopharma (CUE) has disclosed Treasury Shares for 4 consecutive years, with $6667.0 as the latest value for Q2 2022.

  • Quarterly Treasury Shares fell 96.87% to $6667.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $6667.0 through Jun 2022, down 96.87% year-over-year, with the annual reading at $98335.0 for FY2021, 57.25% down from the prior year.
  • Treasury Shares hit $6667.0 in Q2 2022 for Cue Biopharma, roughly flat from $6667.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $263335.0 in Q3 2020 to a low of $6667.0 in Q1 2022.
  • Historically, Treasury Shares has averaged $151334.8 across 4 years, with a median of $172502.5 in 2021.
  • Biggest five-year swings in Treasury Shares: surged 130.0% in 2020 and later crashed 96.87% in 2022.
  • Year by year, Treasury Shares stood at $100000.0 in 2019, then soared by 130.0% to $230002.0 in 2020, then plummeted by 57.25% to $98335.0 in 2021, then crashed by 93.22% to $6667.0 in 2022.
  • Business Quant data shows Treasury Shares for CUE at $6667.0 in Q2 2022, $6667.0 in Q1 2022, and $98335.0 in Q4 2021.